NCT06190899 2025-03-21
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Celcuity Inc
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT03490032 2020-11-17
PROfind
Advanced Accelerator Applications
Phase 1/2 Completed
NCT02606123 2018-03-01
Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
ESSA Pharmaceuticals
Phase 1/2 Terminated
NCT02483884 2017-03-22
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
Life Molecular Imaging SA
Phase 1/2 Terminated
NCT02049190 2015-06-24
Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Arno Therapeutics
Phase 1/2 Unknown